202 related articles for article (PubMed ID: 20413535)
21. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
[TBL] [Abstract][Full Text] [Related]
22. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
[TBL] [Abstract][Full Text] [Related]
23. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
Cave AC; Hurst MM
Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
[TBL] [Abstract][Full Text] [Related]
24. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidence.
Schmier JK; Halpern MT; Jones ML
Drugs Aging; 2005; 22(9):717-29. PubMed ID: 16156676
[TBL] [Abstract][Full Text] [Related]
25. Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
Heerfordt CK; Rønn C; Harboe ZB; Ingebrigtsen TS; Svorre Jordan A; Wilcke JT; Bonnesen B; Biering-Sørensen T; Sørensen R; Holler JG; Itenov TS; Johansen HK; Sivapalan P; Eklöf J; Jensen JS
BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37775111
[TBL] [Abstract][Full Text] [Related]
26. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
Bloom CI; Douglas I; Usmani OS; Quint JK
Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379
[TBL] [Abstract][Full Text] [Related]
27. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
[TBL] [Abstract][Full Text] [Related]
28. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
[TBL] [Abstract][Full Text] [Related]
29. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
Morjaria JB; Rigby A; Morice AH
Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
[TBL] [Abstract][Full Text] [Related]
30. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
Shin J; Park S; Lee JY; Lee JH
Sci Rep; 2024 Jun; 14(1):14703. PubMed ID: 38926519
[TBL] [Abstract][Full Text] [Related]
32. Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.
Lee MC; Lee CH; Chien SC; Chang JH; She HL; Wang JY; Yu MC
Medicine (Baltimore); 2015 Oct; 94(42):e1723. PubMed ID: 26496284
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
Chen W; Johnson KM; FitzGerald JM; Sadatsafavi M; Leslie WD
Arch Osteoporos; 2018 Oct; 13(1):116. PubMed ID: 30374631
[TBL] [Abstract][Full Text] [Related]
34. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β
Chang TY; Chien JY; Wu CH; Dong YH; Lin FJ
Chest; 2020 May; 157(5):1117-1129. PubMed ID: 31887282
[TBL] [Abstract][Full Text] [Related]
35. Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.
Contoli M; Campo G; Pavasini R; Marchi I; Pauletti A; Balla C; Spanevello A; Ferrari R; Papi A
Eur J Intern Med; 2018 Jan; 47():82-86. PubMed ID: 28821412
[TBL] [Abstract][Full Text] [Related]
36. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with inhaled corticosteroids prescription in primary care patients with COPD: A cross-sectional study in the Balearic Islands (Spain).
Román-Rodríguez M; van Boven JF; Vargas F; Contreras CC; Lamelas G; Gestoso S; Góngora M; Corredor M; Esteva M
Eur J Gen Pract; 2016 Dec; 22(4):232-239. PubMed ID: 27597172
[TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Drummond MB; Dasenbrook EC; Pitz MW; Murphy DJ; Fan E
JAMA; 2008 Nov; 300(20):2407-16. PubMed ID: 19033591
[TBL] [Abstract][Full Text] [Related]
40. Inhaled corticosteroids in COPD and the risk of lung cancer.
Lee YM; Kim SJ; Lee JH; Ha E
Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
